TrialCancer2008

Phase 2 trial of pemetrexed disodium and gemcitabine in advanced urothelial cancer (E4802): a trial of the Eastern Cooperative Oncology Group.

Robert Dreicer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.